The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Taysha Gene Therapies, Inc(NASDAQ:TSHA) 
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the t...
Website: http://www.tayshagtx.com
Founded: 2019
CEO: R. A. Session
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Taysha Gene Therapies Days Payable Outstanding ttm (DPO)
Taysha Gene Therapies Op Cashflow Per Share ttm
Taysha Gene Therapies Free Cashflow Per Share ttm
Taysha Gene Therapies Cash Per Share ttm
Taysha Gene Therapies P/S ratio ttm
Taysha Gene Therapies (GAAP) P/E ratio ttm
Taysha Gene Therapies P/B ratio ttm
No extra charts and metrics for this ticker.